FRCS Neurosurgery
Intercollegiate Specialty Fellowship Examination in Neurosurgery (FRCS SN)
Neuro OncologyEnglish
Exam overviewPractice session
A 58-year-old presents with a 6-week history of progressive headache and dysphasia. MRI shows a peripherally enhancing left temporal mass with central necrosis and surrounding T2/FLAIR signal. Histology confirms a WHO grade 4 IDH-wildtype astrocytic tumour. Which molecular marker most strongly predicts benefit from temozolomide and a better prognosis?
Loading your practice session…